Related references
Note: Only part of the references are listed.Management of Postmenopausal Osteoporosis
Panagiota Andreopoulou et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
NADPH oxidases in bone homeostasis and osteoporosis
Katrin Schroeder
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Nox Enzymes and New Thinking on Reactive Oxygen: A Double-Edged Sword Revisited
J. David Lambeth et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Status of drug development for the prevention and treatment of osteoporosis
Peter Schwarz et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
The Women's Health Initiative trial and related studies: 10 years later: A clinician's view
Elizabeth P. Gurney et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Prevention and treatment of postmenopausal osteoporosis
Sri Harsha Tella et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Osteoporosis: Therapeutic Guidelines. Guidelines for Practice Management of Osteoporosis
Sana N. Khan et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2013)
Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis
Robert Josse et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
The role of cytokines in inflammatory bone loss
Pedro P. C. Souza et al.
IMMUNOLOGICAL INVESTIGATIONS (2013)
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis
Claudia Goettsch et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
NF-κB signaling and bone resorption
Y. Abu-Amer
OSTEOPOROSIS INTERNATIONAL (2013)
Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model
So Hee Nam et al.
BONE (2012)
Action of RANKL and OPG for Osteoclastogenesis
Yasuhiro Kobayashi et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
The osteoclast, bone remodelling and treatment of metabolic bone disease
Brendan F. Boyce et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
New insights into osteoclastogenic signaling mechanisms
Tomoki Nakashima et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Therapeutic targeting of osteoclast function and pathways
Matthew L. Broadhead et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Regulation of reactive oxygen species generation in cell signaling
Yun Soo Bae et al.
MOLECULES AND CELLS (2011)
New and Emerging Antiresorptive Treatments in Osteoporosis
Lars Rejnmark et al.
CURRENT DRUG SAFETY (2011)
Methods for Detection and Measurement of Hydrogen Peroxide Inside and Outside of Cells
Sue Goo Rhee et al.
MOLECULES AND CELLS (2010)
NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts
Hideyuki Sasaki et al.
JOURNAL OF MEDICAL INVESTIGATION (2009)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase
Michela G. Schaeppi et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
Parathyroid hormone treatment for osteoporosis
Felicia Cosman
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2008)
Ostreae Testa prevent ovariectomy-induced bone loss in mice by osteoblast activations
Sang Yeob Han et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Antiosteoporotic effect of Polycan, β-glucan from Aureobasidium, in ovariectomized osteoporotic mice
Hyun Dong Shin et al.
NUTRITION (2007)
Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids
Maria Almeida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
Victor G. Vogel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Inactivation of NADPH oxidase organizer 1 -: Results in severe imbalance
PJ Kiss et al.
CURRENT BIOLOGY (2006)
RANKL-RANK signaling in osteoclastogenesis and bone disease
T Wada et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Ghrelin against alendronate-induced gastric damage in rats
SÖ Iseri et al.
JOURNAL OF ENDOCRINOLOGY (2005)
A direct role for dual oxidase in Drosophila gut immunity
EM Ha et al.
SCIENCE (2005)
Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats
S Muthusami et al.
CLINICA CHIMICA ACTA (2005)
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation
NK Lee et al.
BLOOD (2005)
Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation
JM Lean et al.
ENDOCRINOLOGY (2005)
Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia
M Ito et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Efficacy of risedronate on clinical vertebral fractures within six months
C Roux et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase
R Paffenholz et al.
GENES & DEVELOPMENT (2004)
Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes
S Boonen et al.
JOURNAL OF INTERNAL MEDICINE (2004)
A crucial role for thiol antioxidants in estrogen-deficiency bone loss
JM Lean et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
A new superoxide-generating oxidase in murine osteoclasts
S Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
